Abstract
Gastrointestinal stromal tumors (GISTs) are characterized by the presence of activating mutations affecting the c-Kit or the PDGFRA gene. Although these mutations are mutually exclusive, their proteins are coexpressed in many GISTs with various modulations of immunostaining depending on which gene is mutated. CD117 expression is currently considered a sensitive (although not entirely specific) marker of KIT activation, but there is no consensus concerning the reliability of PDGFRA antibody. Our database contains 236 molecularly analyzed GISTs, and we here describe the 180 cases that underwent KIT/PDGFRA immunophenotyping. By correlating the immunophenotype with the molecular status of the genes expected to be involved, we observed the coexpression of KIT and PDGFRA in the majority of the mutated c-Kit and wild-type c-Kit/PDGFRA GISTs, whereas the -/+ immunophenotype (0% vs. 48.6%) and PDGFRA dotlike immunostaining (P
Original language | English |
---|---|
Pages (from-to) | 738-743 |
Number of pages | 6 |
Journal | American Journal of Surgical Pathology |
Volume | 32 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2008 |
Keywords
- Dotlike decoration
- GIST
- Immunohistochemistry
- Molecular analyses
- PDGFRA
ASJC Scopus subject areas
- Anatomy
- Pathology and Forensic Medicine